Insider filing · ORKA
Arjun Agarwal
Senior Vice President, Finance
profile →
Oruka Therapeutics, Inc.
ORKA · Healthcare · 27 filings in 24 months
ticker →
Arjun Agarwal sold $517K of Oruka Therapeutics (ORKA)
Executed May 18, disclosed May 18, the same day.
Value, as filed
$517K
8,790 sh across 2 lots
Executed
May 18
the trade date, as filed
Disclosed
May 18
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
AAArjun Agarwal (Senior Vice President, Finance) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Oruka Therapeutics, Inc. (ORKA). The largest single filing was $1.1M of ORKA (10,000 sh across 5 lots, as filed), executed Aug 13.
The name
ORKAHealthcare · Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psor…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Arjun Agarwal in ORKA
ORKASALE
Oruka Therapeutics, Inc.
$854K9,259 sh across 3 lots
Exec Sep 11
Filed Sep 15 · 7:17 PM ET ORKASALE Oruka Therapeutics, Inc. $1.1M
10,000 sh across 5 lots
Exec Aug 13
Filed Aug 14 · 5:42 PM ET ORKASALE Oruka Therapeutics, Inc. $796K
9,399 sh across 2 lots
Exec Jul 13
Filed Jul 13 · 5:09 PM ET ORKASALE Oruka Therapeutics, Inc. $660K
9,459 sh across 3 lots
Exec Jun 12
Filed Jun 15 · 5:30 PM ET